Previous Seminars

18 Sept 2014
Dr Guillaume Stewart-Jones, NIAID/NIH Vaccine Research Center
Structure guided vaccine design

11 Sept 2014 Prof Daniel Perez, Department of Veterinary Medicine, University of Maryland
Alternative vaccine approaches to protect against influenza

11 July 2014 Prof Alison Elliott, Head of Co-infections Studies Programme, MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda
Immunoepidemiology of infectious diseases in Uganda

23 May 2014
Jeffrey Almond, Dunn School of Pathology, University of Oxford
Building a Vaccines R&D portfolio
 
30 April 2014
Dr Jake Baum, Imperial College London
Dissecting malaria parasite invasion of the human red blood cell: Superb resolution imaging and theoretical thinking…
 
14 April 2014
Prof Danny Douek, Vaccine Research Center, NIAID
Inhibition of inflammation during acute SIV infection
 
14 April 2014
Dr Jean-Simon Diallo, Ottawa Hospital Research Institute
Exploiting pharmaco-viral synergy
 
20 March 2014
Jan ter Meulen, Chief Scientific Officer, ImmuneDesign
Development of a DC-SIGN targeting, integration deficient lentiviral vector for therapeutic vaccination in cancer and chronic infectious disease
 
19 March 2014
Dr Susie Dunachie, Mahidol Oxford Tropical Medicine Research Unit, Bangkok (MORU)
Melioidosis, cellular immunity and diabetes interactions in Thailand
 
17 March 2014
Prof Andrew Sewell, University of Cardiff
Can a systems view of T-cell immunology benefit vaccination?
 
20 Feb 2014 Prof Sir Andrew McMichael, University of Oxford
HIV-1: Know your enemy before making a vaccine
 
17 Oct 2013
Dr Andrew Godkin, Cardiff Institute of Infection & Immunity, Cardiff University School of Medicine
Overcoming the inhibitory effects of tumours on immune responses: from the surgeon's scalpel to immune manipulation
 
23 Sept 2013
Prof Ivan Morrison, The Roslin Institute, Royal (Dick) School of Veterinary Studies, University of Edinburgh
The nature and specificity of T cell responses required for vaccination against Theileria parva
 
23 Sept 2013
Dr Reinhout van Crevel, Radboud University Medical Centre, Nijmegen
BCG and the concept of trained innate immunity
 
19 July 2013
Prof Paul Kaye, Director, Centre for Immunology & Infection, University of York
Immunopathology meets vaccinology: odd bedfellows in leishmaniasis research?
 
11 July 2013 Christian Brander, ICREA Research Professor at IrsiCaixa (Institut de Recerca de la Sida), Barcelona
Alternative approaches to HIV immunogen design
 
17 June 2013
Prof Martin Bachman, The Jenner Institute, University of Oxford
Vaccination against chronic diseases
 
24 May 2013
Prof James McCarthy, Queensland Institute of Medical Research, University of Queensland
Human Malaria Challenge Studies by Blood Stage Inoculation: a tool to define the efficacy of antimalarial drugs and vaccines
 
20 May 2013
Prof William Jacobs, Albert Einstein College of Medicine, New York
Killing Persistent Mycobacterium tuberculosis: Insights from Captain James Cook and Harry Houdini
 
5 April 2013
Prof Chris Tang, Dunn School of Pathology, University of Oxford
Complement evasion by the meningococcus: a hot topic
 
5 March 2013
Prof Miles Carroll, Deputy Director and Head of Research, Microbiology Services Division, Porton Down, Health Protection Agency
The role of animal models for the development of infectious disease vaccines and therapeutics
 
15 Feb 2013
Dr Thomas Churcher, Junior Research Fellow, School of Public Health, Imperial College
Density Dependence in Malaria Transmission and how it may Impact Malaria Sporozoite Challenge Studies
 
8 Feb 2013
Prof Chris Wiethoff, Loyola University Medical Center
Re-engineering the adjuvant properties of Adenovirus vaccine vectors
 
30 Jan 2013
Prof Constantino López-Macías, Medical Research Unit on Immunochemistry, National Medical Centre "Siglo XXI", and Visiting Professor, Nufffield Department of Experimental Medicine, University of Oxford.
The contribution of Salmonella porins in the induction of long lasting immunity to Salmonella infections: Implications for vaccines development
 
19 Nov 2012
Prof Tony Fooks, Head of the Rabies and Wildlife Zoonoses Group, Veterinary Laboratories Agency, Weybridge,
UK Rabies - a neglected zoonoses
 
31 Oct 2012
Prof Peter Mertens, Head of Vector-borne Diseases Programme, Institute for Animal Health
The molecular identification of Bluetongue virus isolates and recent vaccination successes in northern Europe
 
5 Oct 2012
Dr Vish Nene, International Livestock Research Institute, Nairobi, Kenya
A New Livestock Vaccine Initiative
 
26 July 2012
Dr Ed Clarke, NIHR Clinical Lecturer in Paediatrics Institute of Child Life and Health, Bristol University Hospitals
B-cell memory and mucosal immunity following conjugate vaccines
 
30 May 2012
Dr Baptiste Dungu, Senior Director Research and Development, GALVmed
GALVmed: driving technological interventions for the availability and access to control tools on neglected livestock diseases
 
17 May 2012
Prof James Nokes, Infectious Disease Epidemiology, University of Warwick, and Senior Scientist / Research Degree Coordinator KEMRI -Wellcome Trust Research Programme, Kenya
Who should be targeted for RSV vaccination?
 
15 May 2012
Prof Brian Perry, Honorary Professor, College of Medicine and Veterinary Medicine, University of Edinburgh, Visiting Professor of Tropical Veterinary Medicine, University of Oxford, and Honorary Professor, Department of Veterinary Tropical Diseases, University of Pretoria
A market assessment for vaccines against “neglected” livestock diseases in Africa: some lessons learned
 
9 May 2012
Prof Calman MacLennan, Head of Exploratory Programme, Novartis Vaccines Institute for Global Health
Invasive salmonellosis and global health: Understanding immunity, developing vaccines
 
4 May 2012
Dr Claudio Lanata, Scientific Director, US Naval Medical Research Unit 6, Lima, Peru
Opportunities for collaborative vaccine and tropical medicine research in Peru
 
27 April 2012
Dr Daniel Vellom, Snr Director, Global Technology Innovation, Sanofi Pasteur Biologics
Quality by design and the vaccine development conundrum
 
3 April 2012
Dr Guillaume Stewart-Jones, Weatherall Institute for Molecular Medicine, University of Oxford
Incremental progress towards an antibody vaccine to HIV-1
 
23 Jan 2012
Assoc. Prof. Jan Pravsgaard Christensen, University of Copenhagen
Improved immunogenicity of adenoviral vaccines: Impact of tethering the vaccine antigen to MHC-class II associated invariant chain
 
1 Dec 2011
Dr Javier Castillo-Olivares, Institute for Animal Health
Recombinant DNA vaccines for exotic equine viral diseases: Equine viral arteritis and African horse sickness
 
24 Nov 2011
Prof Gavin Wilkinson, Cardiff University School of Medicine
Revisiting and Re-engineering Adenovirus Vectors
 
22 Nov 2011
Dr Laura Martin, Development Project Leader for monovalent Typhi and bivalent
Typhi/Paratyphi A vaccines, Novartis Vaccines Institute for Global Health (NVGH), Siena NVGH’s development of enteric fever vaccines
 
7 Nov 2011
Prof Quentin Sattentau, The William Dunn School of Pathology, University of Oxford
Mucosal adjuvants for HIV vaccines
 
27 Oct 2011
Dr Martin Bachmann, CSO of Cytos Biotechnology, Switzerland
Vaccines against addictions
 
7 Sept 2011
Dr Andreas Neubert, Vice-President Vaccines, IDT Biologika, Germany
Vaccine development - hurdles and chances for new approaches and technologies
 
22 Aug 2011
Prof James Brewer, Institute of Infection, Immunity & Inflammation, University of Glasgow
Imaging the immune system in vivo
 
15 July 2011
Prof Peter J. Hotez, President of the Sabin Vaccine Institute
The “Antipoverty Vaccines” for the Neglected Tropical Diseases
 
10 June 2011
Prof David Lewinsohn, Portland VA Medical Center
Immune Recognition of the Mtb Infected Cell
 
18 April 2011 Prof Robin Shattock, St George's, London Vaccine strategies for focusing humoral immune response on the mucosal portal of HIV entry
 
21 Feb 2011
Prof Sir Marc Feldmann, Kennedy Institute of Rheumatology, Imperial College London
Anti-TNF therapy : past, present and future
 
13 Jan 2011
Dr Allan Saul, Novartis Vaccines Institute for Global Health, Siena
New Vaccines for Enteric Pathogens
 
10 Dec 2010
Prof Bali Pulendran, Emory Vaccine Center, Emory University
Systems biological approaches to vaccinology
 
7 Sept 2010
Prof Robert Sinden, Imperial College London and University of Oxford
Malaria transmission blocking vaccines: Sex, lies & videotapes - 2 out of 3, or 3 out of 3?
 
6 July 2010
Prof Paul Griftiths, Centre for Virology, University College London Medical School
Progress towards vaccines against human cytomegalovirus
 
4 June
2010 Prof Mary Collins, Dean of the Faculty of Life Sciences, University College London
Regulating dendritic cell signalling to improve vaccination
 
18 May 2010
Prof Glyn Hewinson, Veterinary Laboratories Agency
TB Vaccines for Badgers and Cattle: No More Mr. Ten Years!
 
20 April 2010
Prof Paul Fine, Professor of Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine
Vaccines, herd immunity and eradication programmes
 
16 Mar 2010
Prof Andy Morgan, Department of Cellular & Molecular Medicine, University of Bristol
Progress in the development of vaccines for Epstein-Barr virus and its associated diseases
 
14 Jan 2010
Dr Ed Lavelle, School of Biochemistry & Immunology, Trinity College Dublin
Particulate adjuvants for parenteral and mucosal vaccines
 
16 Oct 2009
Prof Dan Barouch, Division of Vaccine Research, Harvard University
Novel Vectors and Antigens for an HIV Vaccine
 
21 Sept 2009
Dr Marie-Paule Kieny, Director, WHO Initiative for Vaccine Research
Vaccine Research and International Health
 
19 Aug 2009
Prof Ian Orme, Colorado State University, College of Veterinary Medicine & Biomedical Sciences
TB: Two scary stories and one marginally disturbing...
 
14 July 2009
Prof Mark Kendall, University of Queensland, Australian Institute for Bioengineering and Nanotechnology
Nanopatches: targeted delivery to skin for improved vaccines
 
16 June 2009
Prof Paul Kaye, University of York, Centre for Immunology and Infection
Therapeutic vaccines for leishmaniasis: lessons from pathology
 
12 May 2009
Prof Alan Rickinson, University of Birmingham, School of Cancer Sciences
Prospects for therapeutic vaccines against Epstein-Barr virus-associated tumours
 
21 April 2009
Dr Satya Parida, Institute for Animal Health, FMD Vaccine Differentiation Group
Vaccination against FMDV: strategies and effectiveness
 
17 March 2009
Prof Sarah Rowland-Jones, MRC and Weatherall Institute for Molecular Medicine, University of Oxford
What can HIV-2 teach us about protective immunity in HIV infection?
 
13 Jan 2009
Dr Dirk Werling, Royal Veterinary College, Dept. of Pathology & Infectious Diseases
Structure-function relationships of Toll-like receptor domains in different species and their potential impact on vaccine design
 
7 Oct 2008
Dr Rachel Midgley, Department of Clinical Pharmacology, University of Oxford
Cancer Vaccines - Principles and Practice
 
9 Sept 2008
Prof Albert Osterhaus, Erasmus MC, University of Rotterdam
Influenza Vaccines
 
26 Aug 2008
Dr David Lewinsohn, Oregon Health & Science University, Molecular Microbiology and Immunology
Recognition of Intracellular Infection with Mtb: The Human CD8 Response to Tuberculosis
 
8 July 2008 Prof John Hermon-Taylor, School of Biomedical and Health Sciences, King's College London
A tutorial on paratuberculosis: New insights into human disease
 
17 June 2008
Dr Robert Harrison, Alistair Reid Venom Research Unit, Liverpool School of Tropical Medicine
New strategies to improve an old therapy - snake antivenom
 
20 May 2008
Prof Dave Stuart, Division of Structural Biology, University of Oxford
Foot and mouth disease virus - structure and vaccine design
 
8 April 2008
Prof Declan McKeever, Royal Veterinary College
 
19 Feb 2008
Dr Paul Klenerman, Peter Medawar Building for Pathogen Research, University of Oxford
HCV Vaccines - Demand and Supply
 
22 Jan 2008
Prof Jonathan Heeney, Comparative Pathology, University of Cambridge
"What Jenner didn't know": Poxviruses which differentially induce CD4 or CD8 T-cells and immunity
 
11 Dec 2007
Dr John Shiver, Vice President Vaccines and Biologics Research, Merck
Merck's HIV Vaccine Programme
 
6 Nov 2007
Prof Mark Stephens (IAH)
Toward control of food-borne diarrhoeal pathogens
 
2 Oct 2007
Prof John Oxford, Oxford
Volunteers for influenza quarantine experiments: from the 1918 pandemic
 
26 Jun 2007
Dr Lucy Dorrell, Compton
Therapeutic HIV vaccines
 
29 May 2007
Dr Venugopal Nair, Oxford
Marek's disease: a natural lymphoma controlled by vaccination
 
24 Apr 2007
Dr Linda Dixon, Oxford
Strategies to produce African swine fever vaccines
 
13 Mar 2007
Prof Richard Moxon, Compton
The challenge of the meningococcus
 
27 Feb 2007
Dr Tom Barrett, Oxford
Rinderpest and PPR vaccines: how can they be improved?
 
23 Jan 2007
Dr Sarah Gilbert, Compton
Replication-deficient viral vaccines
 
13 Dec 2006
Prof Andrew McMichael, Compton
HIV vaccine design
 
12 Dec 2006
Dr Adrian Smith, Oxford
Protective immunity to intracellular infection in the gut: where, how and what is important?
 
21 Nov 2006
Prof Vincenzo Cerundolo, Compton
Harnessing NKT cells in vaccination strategies
 
24 Oct 2006
Dr Jayne Hope, Oxford
Dendritic cells and immune responses to bovine TB
 
21 Sep 2006
Dr Tomas Hanke, Compton
HIV vaccine development
 
02 May 2006
Prof Quentin Sattentau, Compton
The role of reactive carbonyls in vaccine hypersensitivity
 
11 Apr 2006
Dr Helen McShane, Compton
Developing a better TB vaccine: clinical trials with MVA85A
 
04 Apr 2006
Dr Jim Kaufman, Oxford
Avian influenza: the bird’s eye view
 
14 Mar 2006
Dr Andrew Pollard, Compton
B cell responses to conjugate vaccines in infants
 
07 Mar 2006
Dr Geraldine Taylor, Oxford
Bovine RSV vaccines
 
14 Feb 2006
Martin Maiden, Compton
Vaccines against meningococcal disease
 
07 Feb 2006
Dr David Paton & Dr Bryan Charleston, Oxford
Foot and mouth disease virus: strategies to improve vaccines
 
08 Nov 2005
Prof Adrian Hill, Compton
Developing malaria vaccines: bench to bush
 
01 Nov 2005
Sir Gustav Nossal (Opening Symposium), Oxford
Developing country health post-Gleneagles